Clinical Study
Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan
Table 5
Antimicrobial susceptibilities of 14 MRSA strains.
| | Strain | MIC (g/mL) of antimicrobial agents | | MPIPC | ABPC | CCL | CDTR | CAM | CLDM | FOM | MINO | | VCM | NDFX | FA |
| | T-11 | >8 | >16 | >16 | >16 | >16 | >16 | 1 | ≦0.125 | >16 | 2 | ≦0.125 | 0.25 | | T-33 | >8 | 16 | >16 | 4 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-55 | >8 | 16 | >16 | 8 | >16 | >16 | 4 | 0.25 | >16 | 1 | ≦0.125 | 0.25 | | T-64 | >8 | >16 | >16 | >16 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-71 | >8 | 16 | 16 | 4 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | ≦0.125 | | T-79 | >8 | 16 | >16 | 4 | >16 | ≦0.125 | 4 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-83 | >8 | 16 | >16 | 4 | >16 | >16 | 2 | 0.25 | >16 | 1 | ≦0.125 | ≦0.125 | | T-114 | >8 | 16 | >16 | 16 | >16 | >16 | 1 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-119 | >8 | >16 | >16 | >16 | >16 | ≦0.125 | >16 | 16 | >16 | 1 | >16 | 0.5 | | T-125 | 4 | 4 | 4 | 2 | >16 | 0.25 | 4 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-132 | >8 | 16 | >16 | 16 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | ≦0.125 | | T-137 | >8 | >16 | >16 | >16 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | 1 | | T-139 | >8 | 16 | >16 | 16 | >16 | >16 | 2 | ≦0.125 | >16 | 1 | ≦0.125 | 0.25 | | T-144 | >8 | 16 | >16 | 16 | >16 | ≦0.125 | 8 | ≦0.125 | 1 | 1 | ≦0.125 | 0.25 |
|
|
